ArticleInternational journal for numerical methods in biomedical engineering2026
A Fully Automated Pipeline for Vertebral Structural Assessment From Medical Images. Application Under Metastatic Conditions.
Article in International journal for numerical methods in biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Spinal bone metastases often lead to vertebral fractures and other skeletal events that severely affect patients' quality of life. Predicting structural failure is essential for guiding treatment and preventing complications. However, conventional assessment tools have limited predictive power, highlighting the need for computational methods capable of simulating disease progression and its mechanical consequences. This study aimed to develop a fully automated, patient-specific methodology to predict vertebral structural behavior from computed tomography (CT) data, supporting clinical decision-making and treatment planning. The proposed pipeline integrates three main components: a deep neural network for semantic segmentation of vertebrae and metastatic regions from CT scans, the Coherent Point Drift (CPD) algorithm to ensure consistent alignment and automated definition of boundary conditions across datasets, and the Cartesian Grid Finite Element Method (cgFEM) to simulate the vertebral mechanical response under metastatic involvement. Model performance was evaluated by comparing the predicted outcomes with reference data, using precision, sensitivity, and specificity to assess reliability. The proposed workflow achieved full automation from CT imaging to fracture risk estimation. The segmentation module showed high accuracy across multiple metrics, enabling robust model generation. Geometric normalization and CPD-based boundary condition assignment standardized vertebral geometries across studies, while cgFEM simulations provided clinically interpretable metrics such as safety factors and stability variations associated with tumor size, location, and density. These analyses enabled the identification of scenarios linked to a higher fracture risk. The main limitations include the use of fixed boundary conditions and a predefined voxel threshold, which may reduce physiological realism and generate false positives. Overall, this work presents an end-to-end, patient-specific framework for automated fracture risk evaluation in metastatic vertebrae. By combining deep-learning-based segmentation, geometric normalization, CPD alignment, and cgFEM simulations, the method produces clinically relevant outputs that can guide therapeutic strategies. Future developments will focus on integrating patient-specific loading data and predictive modeling to support incorporation into clinical decision support systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.